Thursday, August 01, 2013 3:39:52 PM
Bacterial genomes – 2nd and 3rd generation costs
Leave a reply
There are some really cool developments coming out from PacBio, not least of which is the tantalising ability to be able to sequence and assemble single-contig bacterial genomes (link, link, link).
Adam Phillipy and others have published a really cool paper on this at arXiv, and I have to say I am really, really incredibly impressed by PacBio and all the advances bioinformaticians are making in this area. It’s really cool.
However, in the hype, it’s possible to lose sight of the advantages of the Illumina system, and there are certainly some uncertainties around cost – in the arXiv paper, we see the phrase:
“While the cost of multiplexed Illumina can be as low $300 per genome, the resulting assemblies are typically in hundreds of contigs”
Whilst I don’t have issue with the latter part of that sentence, the first part is perhaps worth questioning!
Some statistics
The rapid-run mode of the HiSeq 2500 is perfectly capable of producing 150 million 150bp paired-end reads. This equates to 45Gb of sequence data.
If we are sequencing 5Mb genomes, at 40X, we need 200Mb of sequence. 96 of those will therefore need ~20Gb of sequence, so as you see, a single lane of HiSeq 2500 easily copes.
ARK-Genomics runs a non-profit full cost recovery business model, which means we charge for reagents, staff time and equipment. So for that lane of sequencing, we would probably charge in the region of £2500.
We need to factor in the cost of libraries. In reality, we could make this cheaper via automation, but for the sake of ease, let’s say the library prep is £100 per sample. That’s £9600 on library prep.
That’s a total of £12100, or £126 per genome.
In reality, I think we could get library prep down to £50 per sample, This would bring the cost down to £76 per genome.
At present exchange rates, $300 is about £200, so you can see our costs are significantly cheaper than the costs in Adam’s paper.
PacBio costs
I have less of an idea about Pac Bio costs – Adam’s paper suggests between $900 and $1200, but admits a different recipe is as high as $2200.
We have commissioned some PacBio work and the cost was about £1100 for a single sample.
Perhaps others can comment on this?
Comparison
My conservative estimate is that PacBio is about 10 times more expensive per sample for bacterial genomes than Illumina, and in reality it is probably higher. Even taking my conservative estimate, the figure of “10 times” is significantly higher than the comparison implied in Adam’s paper. My worry is that Adam’s paper compares an expensive Illumina quote with a cheap PacBio quote.
Pros and Cons
Pros of PacBio are that you get a finished genome.
Pros of Illumina are
1.Cost per sample is far cheaper
2.Population level statistics – I’m not sure of the fold coverage one achieves with PacBio, but 40x Illumina coverage certainly lets you begin to see low-level variants in the population of cells being sequenced
3.Scale – if you want to sequence 96 genomes, the only real option is Illumina – more people have consumables budgets of around £10k than have budgets around £100k
Horses for courses
I love what PacBio are doing, and I love what Adam and others are doing on the Informatics side. At the end of the day, we must choose the right technology for the right question. PacBio is great if you want complete genomes; Illumina is still the only viable alternative if you want to sequence hundreds of bacterial genomes at once.
http://biomickwatson.wordpress.com/2013/08/01/bacterial-genomes-2nd-and-3rd-generation/
Recent PACB News
- PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database • PR Newswire (US) • 06/10/2024 01:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/30/2024 01:52:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:25:43 PM
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
- PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions • PR Newswire (US) • 03/12/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:36:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:26:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:22:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:32:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:22:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:36:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:19:42 PM
- PacBio to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 11:20:57 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM